• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离脂肪酸受体 4 缺失通过 ZBED6-IL33 通路调节 Treg 细胞减轻结肠炎。

Free fatty acid receptor 4 deletion attenuates colitis by modulating Treg Cells via ZBED6-IL33 pathway.

机构信息

Wuxi School of Medicine, Jiangnan University, Wuxi, China; Wuxi Translational Medicine Research Center and Jiangsu Translational Medicine Research Institute Wuxi Branch, China.

School of Food Science and Technology, Jiangnan University, Wuxi, China.

出版信息

EBioMedicine. 2022 Jun;80:104060. doi: 10.1016/j.ebiom.2022.104060. Epub 2022 May 16.

DOI:10.1016/j.ebiom.2022.104060
PMID:35588628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9120243/
Abstract

BACKGROUND

Inflammatory bowel disease (IBD) has complex genetic and environmental aspects, and free fatty acid receptors (FFARs) may bridge genetic and dietary aspects. FFAR4 is highly expressed in the intestine and acts primarily as the receptor of long-chain fatty acids, which are major components of the human diet. It is unclear what role, if any, FFAR4 may play in IBD.

METHODS

Mouse and human colitis samples, mice with complete FFAR4 knockout, intestine-specific FFAR4 knockout and FFAR4 overexpression and cell culture were used. RNA-sequencing analysis and flow cytometry were performed to examine the mechanisms.

FINDINGS

The results showed that FFAR4 expression was upregulated in colitis tissues and that the loss of intestinal FFAR4 ameliorated colitis, whereas intestinal FFAR4 overexpression exacerbated the disease. We identified intestinal epithelial cell deletion of FFAR4 by upregulating ZBED6, which in turn induced L33 transcription, and L33 elevated Treg cell numbers, ameliorating colitis.

INTERPRETATION

FFAR4 deletion attenuates colitis by modulating Treg cells via the ZBED6-IL33 pathway.

FUNDING

National Natural Science Foundation of China, Innovation and Application Project of Medical and Public Health Technology of Wuxi Science and Technology, Fundamental Research Funds for the Central Universities and the Fund of Wuxi Healthcare Commission.

摘要

背景

炎症性肠病(IBD)具有复杂的遗传和环境方面,游离脂肪酸受体(FFARs)可能连接遗传和饮食方面。FFAR4 在肠道中高度表达,主要作为长链脂肪酸的受体,长链脂肪酸是人类饮食的主要成分。FFAR4 在 IBD 中可能发挥什么作用尚不清楚。

方法

使用鼠和人结肠炎样本、完全 FFAR4 敲除小鼠、肠道特异性 FFAR4 敲除和 FFAR4 过表达小鼠以及细胞培养物进行研究。进行 RNA 测序分析和流式细胞术以检查机制。

结果

结果表明,FFAR4 表达在上皮细胞中上调,肠道 FFAR4 的缺失可改善结肠炎,而肠道 FFAR4 的过表达则加剧了疾病。我们通过上调 ZBED6 鉴定了 FFAR4 在肠上皮细胞中的缺失,ZBED6 反过来诱导 L33 转录,L33 增加了 Treg 细胞数量,从而改善了结肠炎。

解释

FFAR4 缺失通过 ZBED6-IL33 途径调节 Treg 细胞来减轻结肠炎。

资助

国家自然科学基金、无锡科技医学和公共卫生技术创新应用项目、中央高校基本科研业务费基金和无锡市卫生健康委员会基金。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/28aa96dc3526/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/6cc069c073b9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/be0ce905d6c2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/1da679953b25/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/4ab23bfc684f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/f136526b5f5c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/e736faf14cd2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/8abbbc278663/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/28aa96dc3526/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/6cc069c073b9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/be0ce905d6c2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/1da679953b25/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/4ab23bfc684f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/f136526b5f5c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/e736faf14cd2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/8abbbc278663/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d646/9120243/28aa96dc3526/gr8.jpg

相似文献

1
Free fatty acid receptor 4 deletion attenuates colitis by modulating Treg Cells via ZBED6-IL33 pathway.游离脂肪酸受体 4 缺失通过 ZBED6-IL33 通路调节 Treg 细胞减轻结肠炎。
EBioMedicine. 2022 Jun;80:104060. doi: 10.1016/j.ebiom.2022.104060. Epub 2022 May 16.
2
Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice.游离脂肪酸受体 4 的激活可影响小鼠的肠道炎症并改善结肠通透性。
Nutrients. 2021 Aug 6;13(8):2716. doi: 10.3390/nu13082716.
3
Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome.在代谢综合征背景下,小胶质细胞Ffar4缺乏会促进认知障碍。
Sci Adv. 2024 Feb 2;10(5):eadj7813. doi: 10.1126/sciadv.adj7813.
4
Characterization of the Synergistic Effect between Ligands of Opioid and Free Fatty Acid Receptors in the Mouse Model of Colitis.在结肠炎小鼠模型中鉴定阿片和游离脂肪酸受体配体的协同作用。
Molecules. 2021 Nov 11;26(22):6827. doi: 10.3390/molecules26226827.
5
Free Fatty Acid Receptor 4 (GPR120) Stimulates Bone Formation and Suppresses Bone Resorption in the Presence of Elevated n-3 Fatty Acid Levels.游离脂肪酸受体4(GPR120)在n-3脂肪酸水平升高时刺激骨形成并抑制骨吸收。
Endocrinology. 2016 Jul;157(7):2621-35. doi: 10.1210/en.2015-1855. Epub 2016 May 4.
6
FFAR4: A New Player in Cardiometabolic Disease?FFAR4:心脏代谢疾病的新靶点?
Endocrinology. 2021 Aug 1;162(8). doi: 10.1210/endocr/bqab111.
7
Free fatty acid receptor 4 activation protects against choroidal neovascularization in mice.游离脂肪酸受体 4 的激活可防止小鼠脉络膜新生血管形成。
Angiogenesis. 2020 Aug;23(3):385-394. doi: 10.1007/s10456-020-09717-x. Epub 2020 Mar 5.
8
Endogenously generated omega-3 fatty acids attenuate vascular inflammation and neointimal hyperplasia by interaction with free fatty acid receptor 4 in mice.内源性生成的ω-3脂肪酸通过与小鼠游离脂肪酸受体4相互作用减轻血管炎症和内膜增生。
J Am Heart Assoc. 2015 Apr 6;4(4):e001856. doi: 10.1161/JAHA.115.001856.
9
In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.多不饱和脂肪酸(PUFAs)在体内对白细胞GPR120/FFAR4的激活对低密度脂蛋白受体敲除小鼠的动脉粥样硬化影响极小。
J Lipid Res. 2017 Jan;58(1):236-246. doi: 10.1194/jlr.M072769. Epub 2016 Nov 3.
10
Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer.脂肪酸谱异常和 FFAR4 信号转导赋予乳腺癌内分泌抵抗性。
J Exp Clin Cancer Res. 2019 Feb 22;38(1):100. doi: 10.1186/s13046-019-1040-3.

引用本文的文献

1
Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies.解码肿瘤微环境中的代谢对话:从免疫抑制到精准癌症治疗
Exp Hematol Oncol. 2025 Jul 22;14(1):99. doi: 10.1186/s40164-025-00689-6.
2
Imbalance in RNA Editing Disrupts Dynamic Neuronal Activity and Olfactory Perception.RNA 编辑失衡破坏动态神经元活动和嗅觉感知。
Int J Mol Sci. 2024 May 30;25(11):5985. doi: 10.3390/ijms25115985.
3
Strategies for targeting cytokines in inflammatory bowel disease.靶向细胞因子治疗炎症性肠病的策略。

本文引用的文献

1
Interleukin-33-Dependent Accumulation of Regulatory T Cells Mediates Pulmonary Epithelial Regeneration During Acute Respiratory Distress Syndrome.白细胞介素-33 依赖性调节性 T 细胞积累介导急性呼吸窘迫综合征肺上皮细胞再生。
Front Immunol. 2021 Apr 15;12:653803. doi: 10.3389/fimmu.2021.653803. eCollection 2021.
2
Novel and Emerging Therapies for Inflammatory Bowel Disease.炎症性肠病的新型和新兴疗法
Front Pharmacol. 2021 Apr 14;12:651415. doi: 10.3389/fphar.2021.651415. eCollection 2021.
3
Inflammatory Bowel Diseases: Is There a Role for Nutritional Suggestions?
Nat Rev Immunol. 2024 Aug;24(8):559-576. doi: 10.1038/s41577-024-01008-6. Epub 2024 Mar 14.
4
Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome.在代谢综合征背景下,小胶质细胞Ffar4缺乏会促进认知障碍。
Sci Adv. 2024 Feb 2;10(5):eadj7813. doi: 10.1126/sciadv.adj7813.
5
FFAR4 activation inhibits lung adenocarcinoma via blocking respiratory chain complex assembly associated mitochondrial metabolism.FFAR4 激活通过阻断与线粒体代谢相关的呼吸链复合物组装抑制肺腺癌。
Cell Mol Biol Lett. 2024 Jan 19;29(1):17. doi: 10.1186/s11658-024-00535-3.
6
supplementation improves glucose tolerance in intestinal knockout mice during the daily light to dark transition.补充剂可改善肠道基因敲除小鼠在每日光暗交替时的葡萄糖耐量。
mSystems. 2023 Oct 26;8(5):e0057323. doi: 10.1128/msystems.00573-23. Epub 2023 Oct 3.
7
Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis.鉴定新型 SCD1 抑制剂可缓解非酒精性脂肪性肝病:肝脂轴的关键作用。
Cell Commun Signal. 2023 Sep 30;21(1):268. doi: 10.1186/s12964-023-01297-9.
8
Fecal Concentrations of Long-Chain Fatty Acids, Sterols, and Unconjugated Bile Acids in Cats with Chronic Enteropathy.患有慢性肠病的猫粪便中长链脂肪酸、甾醇和未结合胆汁酸的浓度
Animals (Basel). 2023 Aug 30;13(17):2753. doi: 10.3390/ani13172753.
9
Loss of ZBED6 Protects Against Sepsis-Induced Muscle Atrophy by Upregulating DOCK3-Mediated RAC1/PI3K/AKT Signaling Pathway in Pigs.ZBED6 缺失通过上调 DOCK3 介导的 RAC1/PI3K/AKT 信号通路来防止猪脓毒症诱导的肌肉萎缩。
Adv Sci (Weinh). 2023 Oct;10(29):e2302298. doi: 10.1002/advs.202302298. Epub 2023 Aug 7.
10
Endogenous -3 PUFAs Improve Non-Alcoholic Fatty Liver Disease through FFAR4-Mediated Gut-Liver Crosstalk.内源性 -3PUFAs 通过 FFAR4 介导的肠-肝串扰改善非酒精性脂肪性肝病。
Nutrients. 2023 Jan 22;15(3):586. doi: 10.3390/nu15030586.
炎症性肠病:营养建议是否起作用?
Nutrients. 2021 Apr 20;13(4):1387. doi: 10.3390/nu13041387.
4
Intestinal Mucosal Wound Healing and Barrier Integrity in IBD-Crosstalk and Trafficking of Cellular Players.炎症性肠病中肠道黏膜伤口愈合与屏障完整性——细胞参与者的相互作用与运输
Front Med (Lausanne). 2021 Mar 23;8:643973. doi: 10.3389/fmed.2021.643973. eCollection 2021.
5
Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science.健康科学领域中游离脂肪酸受体4(FFA4/GPR120)激动剂的研发
Biomol Ther (Seoul). 2021 Jan 1;29(1):22-30. doi: 10.4062/biomolther.2020.213.
6
IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation.白细胞介素-33可驱动产生在皮肤移植中具有增强的体内抑制活性的小鼠调节性T细胞。
Am J Transplant. 2021 Mar;21(3):978-992. doi: 10.1111/ajt.16266. Epub 2020 Sep 15.
7
Molecular Genetic Architecture of Monogenic Pediatric IBD Differs from Complex Pediatric and Adult IBD.单基因遗传性儿童炎症性肠病的分子遗传结构与复杂性儿童及成人炎症性肠病不同。
J Pers Med. 2020 Nov 26;10(4):243. doi: 10.3390/jpm10040243.
8
The Many Functions of Foxp3 Regulatory T Cells in the Intestine.Foxp3+ 调节性 T 细胞在肠道中的多种功能。
Front Immunol. 2020 Oct 20;11:600973. doi: 10.3389/fimmu.2020.600973. eCollection 2020.
9
Regulatory T-cell therapy in Crohn's disease: challenges and advances.克罗恩病的调节性 T 细胞治疗:挑战与进展。
Gut. 2020 May;69(5):942-952. doi: 10.1136/gutjnl-2019-319850. Epub 2020 Jan 24.
10
Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases.游离脂肪酸受体作为炎症性肠病新的潜在治疗靶点。
Pharmacol Res. 2020 Feb;152:104604. doi: 10.1016/j.phrs.2019.104604. Epub 2019 Dec 14.